Drug eruption / Drug hypersensitivity

Drug eruption, also known as drug hypersensitivity reaction, is an adverse immune-mediated response to a medication that manifests primarily through skin changes and lesions. This condition occurs when a cat's immune system incorrectly identifies a drug or its metabolic byproducts as harmful and mounts an inflammatory response against it. Drug eruptions represent a subset of adverse drug reactions and can range from mild, self-limiting skin rashes to severe, potentially life-threatening systemic reactions. While relatively uncommon in cats, drug eruptions are important to recognize because prompt identification and discontinuation of the offending medication are essential for recovery.

Drug hypersensitivity reactions can occur with virtually any medication, although certain drug classes are more commonly implicated than others. The reactions may develop after first-time exposure to a medication following a period of sensitization, or they may occur in cats that have previously tolerated the same medication without problems. The unpredictable nature of drug eruptions means that any cat receiving any medication has some degree of risk, and monitoring for adverse reactions is an important aspect of veterinary care. The reactions are specific to the individual cat's immune response and are not predictable based on the drug's known pharmacological effects.

The impact of drug eruptions on affected cats varies widely depending on the type and severity of the reaction. Mild reactions may cause temporary skin discomfort, itching, and cosmetic changes that resolve once the drug is discontinued. Moderate reactions can produce significant skin lesions, discomfort, and require supportive treatment for complete resolution. Severe reactions, including drug-induced pemphigus, toxic epidermal necrolysis, and drug hypersensitivity syndrome, can be life-threatening and require intensive care. Beyond the immediate effects, drug eruptions complicate future medical care for the affected cat, as the offending medication and potentially related drugs must be avoided permanently.

Drug eruptions are generally treatable when recognized early and managed appropriately. The cornerstone of treatment is immediate discontinuation of the suspected medication, without which the reaction will continue to progress. Supportive care, including anti-inflammatory medications and treatment of any secondary complications, helps the cat recover. The prognosis varies based on the type and severity of the reaction, with most mild to moderate eruptions resolving completely with appropriate care. Early recognition of drug reactions is crucial, and any cat developing new skin lesions or other unusual symptoms while receiving medications should receive prompt veterinary evaluation to assess for possible drug hypersensitivity.

The primary cause of drug eruption in cats is an abnormal immune response to a medication or its metabolites. This occurs when the immune system mistakenly identifies drug molecules as foreign threats and initiates an inflammatory reaction. Unlike predictable drug side effects that occur based on the drug's pharmacological actions and are dose-dependent, drug hypersensitivity reactions are idiosyncratic, meaning they occur unpredictably in certain individuals regardless of the drug dose. Several classes of medications are more commonly associated with hypersensitivity reactions in cats, including certain antibiotics such as sulfonamides, penicillins, and cephalosporins, as well as some anticonvulsants, non-steroidal anti-inflammatory drugs, and cardiac medications.

Genetic factors likely play a role in determining which cats develop drug hypersensitivity reactions, although specific genetic markers have not been well-characterized in felines. Individual variations in drug metabolism, immune system function, and protein binding may influence whether a particular cat's immune system recognizes a drug as foreign. Some cats may have genetic differences in the enzymes that metabolize drugs, leading to accumulation of reactive metabolites that are more likely to trigger immune responses. While drug eruptions are not strictly hereditary in the sense of following a simple inheritance pattern, individual susceptibility appears to have a genetic component.

Environmental and health factors may influence the likelihood of drug hypersensitivity reactions. Cats with compromised immune systems, whether from concurrent disease, immunosuppressive medications, or underlying immune dysfunction, may have altered susceptibility to drug reactions. Concurrent infections, particularly viral infections, have been associated with increased risk of drug hypersensitivity in some species. The route of drug administration may affect reaction risk, with topical applications sometimes causing different reaction patterns than oral or injectable medications. Previous exposure to the same or related drugs is often necessary for sensitization to occur, although some reactions can occur on first exposure.

Risk factors for drug eruption include prior history of drug reactions, concurrent illness, and treatment with medications from drug classes known to be associated with hypersensitivity. Cats receiving multiple medications simultaneously may have increased risk due to greater overall drug exposure and potential drug interactions. Older cats or those with liver or kidney disease may metabolize drugs differently, potentially affecting reaction risk. Cats with a history of allergic conditions, such as atopic dermatitis or food allergies, may have a generally heightened propensity for immune-mediated reactions, although this association is not firmly established for drug hypersensitivity.

The mechanisms underlying drug eruptions involve complex immune system activation. In most cases, the drug molecule is too small to directly trigger an immune response and must first bind to a protein carrier to become immunogenic. This drug-protein complex is then recognized by the immune system as foreign. Different types of hypersensitivity reactions can occur, each with distinct mechanisms. Type I reactions are immediate, immunoglobulin E-mediated responses causing rapid symptoms including urticaria and potentially anaphylaxis. Type III reactions involve immune complex deposition in tissues. Type IV reactions are delayed, T-cell mediated responses that typically develop days after drug exposure and are responsible for many drug eruption patterns. Some severe reactions involve direct T-cell activation without the usual sensitization period. The specific mechanism influences the timing, pattern, and severity of the clinical presentation.

Early warning signs of drug eruption can be subtle and may initially be attributed to the underlying condition being treated rather than to the medication itself. Owners may notice mild redness or warmth of the skin, subtle changes in coat appearance, or slight behavioral changes indicating discomfort. The cat may scratch or groom more than usual, or show mild restlessness. In some cases, mild gastrointestinal symptoms such as decreased appetite or intermittent vomiting may precede obvious skin changes. These early signs can develop within hours to days of starting a new medication, although in some cases, weeks of drug exposure may occur before symptoms appear. Recognizing that any new symptom developing during medication use could represent a drug reaction is important for early intervention.

The most common symptoms of drug eruption involve the skin, although presentations are highly variable. Urticaria, or hives, presenting as raised, itchy welts that may come and go, is a common pattern. Erythema, or diffuse skin redness, may be localized or widespread. Papular eruptions, characterized by small raised bumps on the skin, are frequently seen. Some cats develop maculopapular rashes with both flat and raised components. Vesicles or bullae, which are fluid-filled blisters of varying sizes, may form in some reaction types. More severe reactions can cause erosions and ulcers as the skin sloughs. Hair loss may occur in affected areas. The distribution of lesions varies but may include the face, ears, paw pads, oral cavity, and junction areas between skin and mucous membranes.

Behavioral changes associated with drug eruption reflect the discomfort and systemic effects of the reaction. Affected cats often become lethargic and withdrawn, especially with more severe reactions. Appetite may decrease significantly, and cats may refuse food altogether. Cats with oral lesions may drool, have difficulty eating, or show reluctance to groom. Fever is common with moderate to severe reactions and contributes to malaise. Some cats may vocalize, indicating pain or discomfort. With severe systemic reactions, cats may become depressed, recumbent, or show signs of shock. Any significant behavioral change in a cat receiving medications should prompt evaluation for possible drug reaction.

Physical signs of drug eruption extend beyond the skin in some cases. Facial swelling, particularly of the lips, eyelids, and pinnae, may occur. Conjunctivitis with red, watery eyes is sometimes present. Oral ulcers may be visible in the mouth. Lymph node enlargement may be palpable. In severe reactions, the skin may become fragile and slough in sheets, a life-threatening condition called toxic epidermal necrolysis. Joint swelling or pain may occur with certain reaction types. Respiratory signs may indicate involvement of the airways. Signs of liver or kidney dysfunction, including jaundice or changes in urination, may develop with drug hypersensitivity syndrome affecting internal organs.

Symptom progression in drug eruption depends on the type of reaction and whether the offending drug is continued. With ongoing drug exposure, symptoms typically worsen progressively. Localized reactions may spread to become generalized. Superficial skin changes may progress to erosions and ulcers. Fever and systemic symptoms may intensify. In severe cases, life-threatening complications including sepsis from skin barrier breakdown, organ failure, and shock can develop. Conversely, if the drug is discontinued promptly, many reactions begin to improve within days, although complete resolution may take weeks depending on severity.

Certain symptoms constitute emergencies requiring immediate veterinary attention. Widespread skin sloughing, particularly involving mucous membranes, indicates potentially life-threatening toxic epidermal necrolysis and requires intensive care. Facial swelling, especially if involving the throat and causing breathing difficulty, requires emergency treatment. Signs of anaphylaxis, including collapse, severe weakness, vomiting, and difficulty breathing, are emergencies. High fever with severe lethargy suggests serious systemic involvement. Any rapid deterioration in a cat receiving medications should prompt immediate veterinary evaluation. It is always better to err on the side of seeking care promptly when a drug reaction is suspected.

Diagnosis of drug eruption begins with a thorough veterinary examination and detailed medication history. The veterinarian will perform a comprehensive physical examination, documenting the distribution, character, and severity of skin lesions and any signs of systemic involvement. The medication history is critical and should include all drugs currently being administered, including prescription medications, over-the-counter products, supplements, and topical treatments. The timing of medication initiation relative to symptom onset is important, as most drug eruptions develop within days to weeks of starting the causative medication, although longer timeframes are possible. Information about previous drug reactions in the cat and any family history of drug sensitivities is also relevant.

Diagnostic testing for drug eruption typically includes baseline bloodwork and may include more specialized tests depending on the severity and presentation. Complete blood count may reveal changes such as eosinophilia, which is sometimes associated with allergic reactions, or abnormalities suggesting systemic involvement. Biochemistry panels assess liver and kidney function, which is important both for identifying organ involvement in the reaction and for guiding supportive care. Skin biopsy is often valuable and can reveal histopathological patterns consistent with drug reaction, helping to confirm the diagnosis and exclude other conditions. Culture of skin lesions may be performed if secondary infection is suspected. In cases with suspected internal organ involvement, additional testing such as urinalysis, imaging, or organ-specific function tests may be indicated.

Differentiating drug eruption from other skin conditions is challenging because drug reactions can mimic many other dermatological diseases. Infectious skin diseases, including bacterial, viral, and fungal infections, must be considered and may require specific testing to exclude. Autoimmune skin diseases such as pemphigus can produce similar lesions and may even be drug-induced in some cases. Other allergic conditions, including atopic dermatitis, food allergy, and contact dermatitis, cause skin changes that may resemble certain drug eruption patterns. Neoplastic conditions occasionally produce skin changes that could be confused with drug reactions. The temporal relationship to medication use and the clinical presentation help guide differentiation, but definitive diagnosis often relies on response to drug withdrawal.

Confirmation of drug eruption is primarily based on clinical grounds, as specific tests to identify the causative drug are limited in veterinary medicine. The most definitive evidence is improvement following discontinuation of the suspected drug and recurrence if the drug is re-administered, although rechallenge is generally not recommended due to the risk of more severe reaction. In many cases, multiple medications are being administered, and identifying the specific culprit requires systematic consideration of each drug's likelihood of causing the observed reaction pattern. Response to drug discontinuation, while supportive of the diagnosis, is not absolutely confirmatory because some conditions may coincidentally improve during the same timeframe. Skin biopsy findings consistent with drug reaction and exclusion of other likely diagnoses support the diagnosis in most clinical situations.

The immediate and most critical treatment for drug eruption is discontinuation of the offending medication. If the causative drug can be identified, it should be stopped immediately. In cases where multiple medications are being administered and the specific cause is uncertain, all non-essential medications should be discontinued while essential medications are evaluated for continuation versus substitution with alternatives from different drug classes. Early drug withdrawal is associated with better outcomes, as continued drug exposure allows the reaction to progress. If the medication is essential for treating a serious underlying condition, careful risk-benefit analysis and close monitoring are required, ideally with consultation with a veterinary specialist.

Medical management of drug eruption focuses on reducing inflammation, managing symptoms, and treating any complications. Systemic corticosteroids are commonly used to suppress the immune-mediated inflammatory response and are particularly important for moderate to severe reactions. The dose and duration depend on the severity of the reaction, with higher doses and longer courses needed for more severe cases. Antihistamines may provide some symptomatic relief, particularly for urticarial reactions, although their efficacy is limited. Analgesics may be needed for pain management if significant skin erosions or ulcers are present. Antibiotics are indicated if secondary bacterial infection of damaged skin has occurred. Intravenous fluid therapy may be necessary for cats with severe reactions causing dehydration or systemic compromise.

Surgical intervention is not typically a primary treatment for drug eruption, but wound management may be necessary for cats with severe skin damage. Cases of toxic epidermal necrolysis or other severe reactions with extensive skin sloughing require intensive wound care similar to burn treatment. This may include careful debridement of necrotic tissue, application of appropriate wound dressings, and meticulous hygiene to prevent infection. In severe cases, escharotomy or other surgical procedures may be needed to manage compartment syndrome from circumferential wounds. These severe cases require specialized intensive care and often referral to a facility with appropriate capabilities.

Supportive care is essential for cats recovering from drug eruption, particularly for more severe cases. Maintaining hydration through intravenous fluid therapy supports organ function and tissue healing. Nutritional support, including feeding tubes if the cat cannot eat normally due to oral lesions, ensures adequate caloric intake during recovery. Environmental management includes keeping the cat in a clean, comfortable environment and preventing self-trauma to damaged skin. Elizabethan collars or other protective measures may be needed. Body temperature regulation is important for cats with extensive skin loss who cannot thermoregulate normally. Gentle handling to avoid further skin trauma is essential. Pain management ensures the cat's comfort during healing.

Alternative and complementary approaches to treating drug eruption are limited, and the focus should remain on drug discontinuation and conventional supportive care. Some topical treatments, such as gentle emollients, may provide comfort for irritated skin. Oatmeal-based baths may soothe mild reactions if tolerated. Omega-3 fatty acid supplementation may support skin barrier recovery, although effects are modest. Any alternative treatments should be discussed with the veterinarian to ensure they do not interfere with healing or contain ingredients that might cause additional reactions. The priority in drug eruption management is always immediate drug discontinuation and appropriate medical care.

Treatment decisions for drug eruption are guided by the severity of the reaction and the individual patient's circumstances. Mild reactions may be managed on an outpatient basis with drug discontinuation and oral medications. Moderate reactions often require more intensive monitoring and may need hospitalization for parenteral medications and fluid therapy. Severe reactions, particularly toxic epidermal necrolysis and drug hypersensitivity syndrome with organ involvement, require intensive hospitalization and carry guarded prognoses. Cost considerations are significant for severe cases requiring extended hospitalization and intensive care. The need for the discontinued medication to treat the underlying condition complicates management and may require identification of alternative treatments. Documentation of the drug reaction in the cat's medical record is essential to prevent future exposure.

Recovery timeline for drug eruption varies substantially based on the type and severity of the reaction. Mild reactions, such as simple urticaria or localized rashes, often begin improving within twenty-four to seventy-two hours of drug discontinuation and may resolve completely within one to two weeks. Moderate reactions with more extensive skin involvement typically require two to four weeks for complete resolution, although significant improvement is usually apparent within the first week. Severe reactions, including toxic epidermal necrolysis, may require weeks to months of recovery, and some patients may have permanent consequences. The speed of recovery is influenced by how quickly the drug was discontinued and how promptly appropriate supportive care was initiated.

Post-treatment care for cats recovering from drug eruption involves continued monitoring and supportive measures as the skin heals. Medications prescribed for managing the reaction, such as corticosteroids, should be tapered according to the veterinarian's instructions rather than stopped abruptly. Ongoing wound care may be necessary for cats with skin erosions or ulcers until complete epithelialization occurs. Follow-up veterinary appointments assess healing progress and detect any complications. Nutritional support continues until the cat is eating normally. Protecting the cat from self-trauma and maintaining a clean environment supports healing. Owners should monitor for any signs of recurring skin changes or systemic symptoms that might indicate incomplete resolution or development of complications.

Prognosis for drug eruption depends heavily on the type and severity of the reaction. Cats with mild reactions that are promptly recognized and managed have excellent prognoses, with complete recovery expected. Moderate reactions also generally have good prognoses, although recovery may take longer and temporary skin changes or hair loss may occur. Severe reactions, particularly toxic epidermal necrolysis and drug hypersensitivity syndrome with organ involvement, carry guarded to poor prognoses, with significant mortality risk even with aggressive treatment. Survival of severe reactions may be followed by prolonged recovery and potential permanent scarring or organ damage. The most important prognostic factor is early recognition and drug discontinuation.

Long-term outlook for cats that recover from drug eruption is generally good, with most experiencing no lasting effects once healing is complete. However, the cat will remain permanently sensitized to the offending drug and must never receive it again, as re-exposure could trigger a more severe reaction. Related drugs from the same class may also need to be avoided due to potential cross-reactivity. Documentation of the drug reaction is essential and should be prominently noted in the cat's medical records. Owners should inform all future veterinary providers of the drug reaction. With appropriate avoidance of the causative drug, recovered cats typically live normal lives without ongoing complications from the previous reaction.

Primary prevention of drug eruption is challenging because reactions are unpredictable and can occur with any medication. However, certain measures can reduce risk and facilitate early detection. Avoiding unnecessary drug use and prescribing only medications that are truly needed reduces overall exposure risk. When possible, choosing drugs with lower reported rates of hypersensitivity reactions may be preferable. Before prescribing new medications, veterinarians should ask about any history of previous drug reactions in the cat or related animals. Starting with lower doses when appropriate and monitoring closely during initial treatment allows for early detection of reactions. Owners should be informed about potential signs of drug reactions and instructed to report any unusual symptoms promptly.

For cats with a history of drug reaction, preventing future reactions is paramount. The specific drug that caused the reaction must be permanently avoided, and this information should be prominently documented in the cat's medical records. Related drugs from the same class may need to be avoided due to potential cross-reactivity, although this varies depending on the specific drugs involved. Before any new medications are prescribed, the history of drug reaction should be reviewed. If the cat requires treatment with a medication that carries concern for cross-reactivity, careful risk-benefit analysis and close monitoring are essential. Pre-treatment with antihistamines or corticosteroids is sometimes considered when a potentially cross-reactive drug must be used, although this approach has limited evidence and does not guarantee prevention.

Dietary factors do not specifically prevent drug eruption, but overall health maintenance supports the body's ability to handle medications appropriately. Maintaining good nutrition supports immune system function and organ health. Ensuring adequate hydration supports drug metabolism and excretion. Keeping the cat at a healthy weight avoids altered drug distribution that can occur with obesity. Minimizing concurrent stressors supports normal physiological function. While these measures cannot prevent idiosyncratic drug reactions, they contribute to overall health and may improve tolerance of necessary medications.

Regular health maintenance and careful veterinary care reduce the risks associated with drug use. Regular veterinary examinations help detect underlying conditions that might affect drug metabolism or increase reaction risk. Monitoring organ function, particularly liver and kidney function, before initiating drugs that are metabolized or excreted by these organs helps ensure appropriate drug selection and dosing. Minimizing polypharmacy when possible reduces overall drug exposure and potential for interactions. Using the lowest effective dose of necessary medications limits exposure while maintaining therapeutic benefit. Regular reassessment of the need for ongoing medications allows for discontinuation of drugs that are no longer necessary.

Early intervention when drug reaction is suspected can prevent progression to more severe disease. Owners should monitor cats receiving any medication for changes in behavior, appetite, or skin condition. Any new symptoms developing during medication use should be reported to the veterinarian promptly. If a drug reaction is suspected, the veterinarian may recommend discontinuing the medication while the situation is assessed. Prompt drug discontinuation at the first signs of reaction, before severe skin damage or systemic involvement develops, significantly improves outcomes. Education of cat owners about potential drug reaction signs empowers them to recognize problems early and seek appropriate care.

Daily management for cats that have experienced drug eruption primarily involves strict avoidance of the causative medication and vigilant monitoring when any new medications are needed. Owners should maintain an up-to-date list of all medications the cat has reacted to, including specific drug names, reaction types, and approximate dates. This list should be readily accessible and shared with any veterinarian who may treat the cat, including emergency clinicians. When the cat requires medical treatment, this history should be discussed before any medications are prescribed. Owners should verify that any prescribed medication is not the same as or closely related to the previous reaction trigger.

Creating a safe medication environment for cats with drug reaction history involves several considerations. All medications in the household should be stored securely to prevent accidental ingestion of drugs the cat should avoid. Family members and caregivers should be informed about the cat's drug sensitivity. If multiple pets are in the household and one requires a medication that the sensitive cat should avoid, care must be taken to prevent accidental exposure through shared food bowls, grooming, or contact with treated areas. For cats requiring ongoing medications for other conditions, establishing a consistent medication routine with careful observation for any adverse effects is important.

Maintaining quality of life for cats with drug reaction history is generally straightforward, as the condition does not cause ongoing symptoms once the reaction has resolved. Cats that have fully recovered can resume all normal activities without restrictions. The primary impact is on future medical care, where drug selection may be somewhat limited. Fortunately, alternatives to most drugs exist, so effective treatment for future health issues is usually possible. Regular wellness care, including appropriate vaccinations and preventive treatments, should continue with attention to selecting safe products. Owners should not avoid necessary veterinary care out of fear of drug reactions, but rather ensure that the cat's history is known and appropriate precautions are taken.

Ongoing monitoring for cats with drug reaction history includes being alert for any signs of reaction when new medications are introduced. Even medications that are expected to be safe should be monitored, as cats that have had one drug reaction may potentially react to other, unrelated drugs. The monitoring period is most important during the first few days to weeks of a new medication. Owners should know the signs of drug eruption and report any concerning changes to the veterinarian promptly. Regular veterinary check-ups provide opportunity to discuss ongoing medication needs and update the allergy list. If the cat develops new health conditions requiring treatment, discussing the drug reaction history with the veterinarian ensures safe medication selection.

Support for owners of cats with drug reaction history is generally straightforward, as the condition does not require ongoing treatment once resolved. The main challenges are remembering and communicating the drug sensitivity information and potentially managing anxiety about future medication needs. Keeping clear records helps reduce stress about remembering specific details. Understanding that while the specific drug must be avoided, alternative treatments are usually available for most conditions provides reassurance. Establishing a relationship with a primary veterinarian who knows the cat's history and can guide medication decisions provides continuity of care. For cats with severe previous reactions or complex medical needs requiring multiple medications, consultation with a veterinary specialist may provide additional expertise and support.

Drug eruption is not strongly associated with specific cat breeds, as the condition depends on individual immune system responses rather than breed-specific genetic factors. Any cat receiving medications has some risk of developing a drug hypersensitivity reaction, and this risk does not appear to be significantly higher or lower in particular breeds. The idiosyncratic nature of drug reactions means that they occur unpredictably in individual cats across all breed backgrounds. While there may be individual genetic factors that influence drug metabolism and immune responses, these have not been characterized in ways that allow prediction of which cats will react to specific medications.

Mixed breed cats and purebred cats appear to have similar risks for drug eruption. The primary risk factor is drug exposure rather than breed background. Cats with individual or familial history of drug reactions may have increased risk, suggesting some genetic component to susceptibility, but this does not follow breed lines. Cats with underlying immune system abnormalities or those receiving immunomodulating medications may have altered susceptibility to drug reactions, but again, this is not breed-specific. All cats receiving medications should be monitored for potential adverse reactions regardless of their breed.

Because drug eruption risk is not breed-specific, there are no breed-based screening recommendations. General precautions apply to all cats receiving medications, including careful history taking before prescribing new drugs, starting with appropriate doses, and monitoring for adverse effects. For cats with individual history of drug reaction, strict avoidance of the causative drug and related compounds is essential regardless of breed. Breeders cannot screen for drug reaction susceptibility and should not make breeding decisions based on drug reaction history in individual cats unless a clear familial pattern is apparent. The focus for all cat owners and veterinarians should be on appropriate drug selection, monitoring, and prompt recognition of reactions if they occur.

Drug eruption may occur in cats that have other immune-mediated or allergic conditions, reflecting an underlying tendency toward immune hyperreactivity. Cats with atopic dermatitis, food allergy, or other allergic conditions may have a generally heightened propensity for immune-mediated reactions, although the specific relationship to drug hypersensitivity is not firmly established. Some cats that experience drug eruption may later be diagnosed with or develop other autoimmune or immune-mediated conditions. Conversely, cats with existing autoimmune diseases may be receiving immunosuppressive medications that affect their response to other drugs. Comprehensive assessment of a cat's overall immune health may be warranted in cases of severe or unusual drug reactions.

Several conditions can be confused with drug eruption and must be distinguished for appropriate management. Primary autoimmune skin diseases, such as pemphigus, can produce lesions similar to those seen in drug eruption and may even be triggered by drugs in some cases. Infectious skin diseases, including bacterial pyoderma and dermatophytosis, can resemble some drug eruption patterns. Other allergic skin conditions, including atopic dermatitis and contact dermatitis, may produce similar lesions but have different causes and treatments. Neoplastic conditions occasionally cause skin changes that could initially be mistaken for drug reactions. Careful history taking, attention to the temporal relationship with medication use, and appropriate diagnostic testing help distinguish these conditions.

Complications of drug eruption can affect multiple organ systems in severe cases. Secondary bacterial infection of damaged skin is a common complication that requires antimicrobial treatment. In severe cases with extensive skin loss, fluid and electrolyte imbalances, hypothermia, and sepsis can develop. Drug hypersensitivity syndrome involves internal organ damage, most commonly affecting the liver, and can cause persistent illness even after drug discontinuation. Some drug reactions can trigger ongoing autoimmune processes that persist after the drug is stopped. Permanent scarring, pigmentation changes, or hair loss may occur in areas of severe skin damage. Recognition and management of these complications is important for optimal outcomes in cats with drug eruption.